South African Biotech start-up Immobazyme secures $1.3m investment to expand its production capabilities

South African biotechnology start-up Immobazyme has secured $1,3 million (R24.5m)  bringing its total investment raised to date to R24.5 million. Founded in 2019 by Dominic Nicholas, Ethan Hunter, and Nicholas Enslin , Immobazyme is a South African biotechnology spin-out company of Stellenbosch University that utilizes precision fermentation to produce high-value active protein ingredients…
Read More